JW Shinyak Corporation (KOSDAQ: 067290)
South Korea flag South Korea · Delayed Price · Currency is KRW
1,665.00
-33.00 (-1.94%)
Dec 20, 2024, 9:00 AM KST

JW Shinyak Company Description

JW Shinyak Corporation engages in the production, sale, and research and development of medicines and medical supplies in South Korea.

It offers pharmaceutical products in the areas of dermatology, urology, pediatrics, otolaryngology, etc.; and cardiovascular, gastrointestinal, urinary, NSAIDs, antibiotics, anti-fungal, anti-viral, respiratory, antihistamines, steroid hormone, anti-obesity, and other products, as well as eye drops, and antitussives and expectorants.

The company also develops prostate cancer treatment, liver cancer treatment, rheumatoid arthritis treatment, etc. using immune cells.

JW Shinyak Corporation was founded in 1981 and is headquartered in Gwacheon, South Korea.

JW Shinyak Corporation
Country South Korea
Founded 1981
Industry Orthopedic, Prosthetic, and Surgical Appliances and Supplies
Employees 197
CEO Yong-Kwan Kim

Contact Details

Address:
JW Tower
Gwacheon, 13840
South Korea
Phone 82 2 2109 3300
Website jw-shinyak.co.kr

Stock Details

Ticker Symbol 067290
Exchange KOSDAQ
Fiscal Year January - December
Reporting Currency KRW
SIC Code 3842

Key Executives

Name Position
Yong-Kwan Kim Chief Executive Officer